Cargando…
The impact of chemotherapy dose intensity and supportive care on the risk of febrile neutropenia in patients with early stage breast cancer: a prospective cohort study
BACKGROUND: Febrile neutropenia (FN) is a major dose-limiting toxicity of cancer chemotherapy resulting in considerable morbidity, mortality, and cost. This study evaluated the time course of neutropenic events and patterns of supportive care interventions in patients receiving chemotherapy for earl...
Autores principales: | Culakova, Eva, Poniewierski, Marek S, Wolff, Debra A, Dale, David C, Crawford, Jeffrey, Lyman, Gary H |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4524886/ https://www.ncbi.nlm.nih.gov/pubmed/26251780 http://dx.doi.org/10.1186/s40064-015-1165-6 |
Ejemplares similares
-
Patterns of chemotherapy-associated toxicity and supportive care in US oncology practice: a nationwide prospective cohort study
por: Culakova, Eva, et al.
Publicado: (2014) -
Hodgkin lymphoma treatment with ABVD in the US and the EU: neutropenia occurrence and impaired chemotherapy delivery
por: Schwenkglenks, Matthias, et al.
Publicado: (2010) -
Chemotherapy-Induced Neutropenia and Febrile Neutropenia in the US: A Beast of Burden That Needs to Be Tamed?
por: Boccia, Ralph, et al.
Publicado: (2022) -
Assessing patients’ risk of febrile neutropenia: is there a correlation between physician-assessed risk and model-predicted risk?
por: Lyman, Gary H, et al.
Publicado: (2015) -
Management of chemotherapy-associated febrile neutropenia
por: Cameron, D
Publicado: (2009)